Bayesian data monitoring in clinical trials

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Unknown venue

• Publication date

  1997-06-30

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated

  1994cited by this paper
• Controversies in meta-analysis: the case of the trials of serum cholesterol reduction

  1993cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• Probability of success and group sequential designs

  2023cites this paper
• Applied Bayesian Approaches for Research in Motor Neuron Disease

  2022cites this paper
• Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study

  2018cites this paper
• Inflammation and Autonomic Function

  2018cites this paper
• Idle thoughts of a ‘well‐calibrated’ Bayesian in clinical drug development

  2016cites this paper
• An introduction of Bayesian statistics to clinicians

  2011cites this paper
• List of Distributions

  2011cites this paper
• Some Special Traveling Salesman Problems with Applications in Health Economics

  2010cites this paper
• Bayesian Design of Single-arm Phase II Clinical Trials with Continuous Monitoring

  2009cites this paper
• Bayesian interim analysis in clinical trials.

  2008cites this paper
• Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma

  2007cites this paper
• Bayesian evaluation of group sequential clinical trial designs

  2007cites this paper
• A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

  2007cites this paper
• Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

  2006cites this paper
• Phase II Clinical Trials in Oncology: Strengths and Limitations of Two-Stage Designs

  2006cites this paper
• Curious phenomena in Bayesian adjustment for exposure misclassification

  2006cites this paper
• Where's the utility in Bayesian data-monitoring of clinical trials?

  2005cites this paper
• Computational Epidemiology: Bayesian disease Surveillance

  2005cites this paper
• Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?

  2005cites this paper
• Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.

  2003cites this paper
• Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

  2002cites this paper
• Hidden Markov Models for Analysis of Biological Rhythm Data

  2002cites this paper
• Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction.

  2002cites this paper
• Using Prior Opinions to Examine Sample Size in Two Clinical Trials

  2002cites this paper
• Quantifying and documenting prior beliefs in clinical trials

  2001cites this paper
• Bayesian methods in health technology assessment: a review.

  2000cites this paper
• Evidence-based medicine as Bayesian decision-making.

  2000cites this paper
• An introduction to bayesian methods in health technology assessment

  1999cites this paper
• assessment introduction to bayesian methods in health Methods in health service research

  1999cites this paper
• Bayesian Methods an Example Mathematical Formalization

  year unknowncites this paper